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Summary
A key step in cell migration is the dynamic formation and
disassembly of adhesions at the front and the concomitant
movement and release of adhesions in the rear of the cell.
Fibroblasts maintained in the absence of serum have stable
adhesions within the rear of the cell and exhibit reduced
trailing-edge retraction resulting in an elongated cell phenotype.
Addition of lysophosphatidic acid (LPA) induced the movement
of adhesions and retraction of the trailing edge, thus mimicking
tail retraction in a migrating cell. Focal adhesion kinase (FAK),
guanine nucleotide exchange factors (GEF) for Rho and the Rho
effector Rho kinase II (ROCKII) are crucial for the regulation
of adhesion movement and trailing-edge retraction.
Downregulation of FAK by small interfering RNAs or small
hairpin RNAs blocked LPA-induced adhesion movement and
restoration of cell shape. This phenotype was rescued by the

Introduction
Fibroblast migration is a highly regulated process that leads to a
distinct migratory polarity (Ridley et al., 2003). Protrusion of the
leading edge and the establishment of new peripheral adhesions
coupled with the maintenance of stable attachments at the cell rear
create the typical asymmetrical profile of a migrating cells with a
broad lamellipodia (front) and narrow long trailing edge (rear)
(Regen and Horwitz, 1992). As the lamellipodia advances and the
trailing edge stretches the cell becomes elongated. Inward movement
and subsequent release of adhesions at the rear leads to trailingedge retraction and cell body advance whereupon the cell becomes
more rounded (symmetrical) and the cycle is repeated (Rid et al.,
2005; Smilenov et al., 1999; Webb et al., 2005). Fibroblast
movement requires spatial regulation of cell attachment to extra
cellular matrix (ECM). Adhesions are formed at sites of
lamellipodial protrusion. Once formed, these adhesions must be
strong enough to generate traction forces necessary to support
translocation of the cell body. However, the trailing edge of the
cells must be able to detach from the substrate to permit cell
translocation (Regen and Horwitz, 1992). Detachment of the trailing
edge requires continued myosin-driven cytoskeletal tension that
results in movement and ultimate release (disassociation/
degradation) of adhesions within the trailing edge (Palecek et al.,
1998; Palecek et al., 1996; Rid et al., 2005; Smilenov et al., 1999).

ectopic expression of PDZ-RhoGEF or a RhoA-effector-domain
mutant that activates ROCK. Knockdown of PDZ-RhoGEF or
ROCKII inhibited LPA-induced trailing-edge retraction and
adhesion movement. Moreover, overexpressed PDZ-RhoGEF
co-immunoprecipitated with FAK and localized to FAKcontaining adhesions. These studies support a model in which
FAK and PDZ-RhoGEF cooperate to induce Rho/ROCKIIdependent focal adhesion movement and trailing-edge
retraction in response to LPA.

Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/121/6/895/DC1
Key words: Kinase, Migration, GTPase, Adhesion

The nature of the signals that promote dissociation/degradation of
the adhesions in the trailing edge is poorly understood.
Lysophosphatidic acid (LPA) stimulation of several cell types
induces tyrosine phosphorylation and activation of focal adhesion
kinase (FAK) (Bian et al., 2006; Luttrell et al., 1997; Seufferlein
and Rozengurt, 1994). FAK is a non-receptor tyrosine kinase that
is associated with adhesions (Hildebrand et al., 1993; Schaller et
al., 1992), sites of close contact between the cell and the extracellular
matrix. FAK is activated in response to integrin engagement and
its phosphorylation leads to the recruitment and activation of Src,
and the induction of several downstream signaling pathways
(Parsons, 2003; Parsons et al., 1994). In addition FAK serves as a
scaffold for the recruitment of the linker protein p130Cas (BCAR1)
(Burnham et al., 1996), and the two GTPase-activating proteins
ASAP1 (ARF GTPase-activating protein 1, DDEF1) (Liu et al.,
2002) and GRAF (GTPase regulator associated with focal
adhesions) (Hildebrand et al., 1996). Thus, FAK functions to recruit
proteins that contribute to the regulation of adhesion signaling and
promotes the dynamic remodeling of adhesions by triggering
adhesion disassembly through a Src- and MEK-dependent cascade
(Webb et al., 2004). Cells deficient for FAK exhibit defects in
adhesion disassembly (Webb et al., 2004) and Rho regulation upon
integrin (Ren et al., 2000) or LPA receptor stimulation (Palazzo et
al., 2004)
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In the present study, we investigate the role of LPA, FAK and
PDZ-RhoGEF [PDZ-domain-containing Rho guanine nucleotide
exchange factor; PDZ RhoGEF (human); GTRAP48 (rat)] in the
regulation of adhesion movement, trailing-edge retraction and cellshape change. We observed that maintaining fibroblasts in the
absence of serum results in stabilization of adhesions within the
rear of the cell, and significantly reduced trailing-edge retraction
resulting in an elongated cell phenotype. LPA but not PDGF was
sufficient to restore trailing-edge retraction and to increase inward
movement of adhesions, and to restore cell shape. Thus, the
response of serum-deprived cells to LPA parallels events that lead
to tail retraction in a migrating cell. Using this paradigm, we provide
evidence that LPA induces dynamic movement of adhesions present
in the trailing edge, and this process requires function of FAK, PDZRhoGEF and Rho/Rho kinase II (ROCKII). This study provides
evidence for the spatial activation of an LPA-receptor–FAK–PDZRhoGEF signaling complex and suggests that modulation of
adhesion movement within the trailing edges of fibroblasts is linked
to Rho/ROCKII-dependent retraction.
Results

Journal of Cell Science

LPA stimulates trailing-edge retraction and rear-adhesion
dynamics

NIH3T3 cells, cultured on fibronectin and deprived of serum for 6
hours, acquired a distinct morphology characterized by a protrusive

Fig. 1. Serum starvation of NIH3T3
cells results in failure of trailingedge retraction. (A) Length of the
trailing edge and protrusion rates in
NIH3T3 cells stably expressing
βactin-mRFP cultured without serum
or without serum but plus 2 μM
LPA. For trailing-edge measurement,
cells were filmed for 6 hours
immediately after serum removal
with images acquired at 5-minute
intervals, using phase-contrast
microscopy. Images acquired at the
end of the sixth hour were quantified
are shown. Data represent the
analysis of 60 cells from two
different experiments. For protrusion
of the lamellipodia, cells were
starved for 6 hours and at the end of
sixth hour, images of βactin-mRFP
in protruding lamellipodia were
obtained for 20 minutes at 20-second
intervals. The data represent analysis
of six protruding lamellipodia per
experimental condition. (B) Phasecontrast images and quantification of
cell elongation of serum-starved
cells, serum-starved cells treated
with 2 μM LPA or 100 nM PDGF.
Data represent the analysis of 50-72
cells per condition from two
different experiments. (C) Kinetics
of changes in cell elongation
following LPA stimulation of serumstarved fibroblasts.

lamellipodia and an elongated tail-like structure, which was
approximately four times longer than control cells deprived of serum
but then treated with LPA (Fig. 1A). Interestingly, the rate of
lamellipodia protrusion (as visualized by actin-rich structures in
βactin-expressing cells) was the same in cells kept without serum
and stimulated with LPA (Fig. 1A). Cells that had been serumstarved overnight (12-16 hours) also displayed an elongated
phenotype with substantially less protrusive activity (Fig. 1B).
Stimulation of serum-starved NIH3T3 cells with 2 μM LPA induced
the retraction of the elongated tail and restored normal cell
morphology, whereas addition of 100 nM PDGF was much less
effective at inducing normal morphology (Fig. 1B). Time-lapse
imaging of serum-starved cells stimulated with 2 μM LPA revealed
that restoration of the normal rounded morphology occurred with
a t1/2 of 90-120 minutes (Fig. 1C and supplementary material Movie
1). To assess whether the LPA induced trailing-edge retraction was
reflected in changes in the dynamic behavior of adhesions, TIRF
microscopy was used to monitor focal adhesions labeled with
paxillin conjugated to GFP (paxillin-GFP) in cells serum starved
overnight and in LPA-stimulated cells. As shown in Fig. 2A and
supplementary material Movie 2, adhesions present in the rear of
serum-starved cells did neither exhibit a change in fluorescence
intensity nor in position, indicating that these adhesions were
relatively stable. By contrast, LPA stimulation substantially
increased the dynamics of adhesions, as measured by the inward
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Fig. 2. LPA stimulation of adhesion movement. Rat2 or NIH3T3 cells stably expressing GFP-FAK or paxillin-GFP were plated in the presence of serum-containing
(10%) medium on dishes coated with 1 μg/ml fibronectin. The following day, cells were placed in serum-free medium for 12 hours and subsequently stimulated
with 2 μM LPA. (A) Analysis of adhesion movement in response to LPA. Serum starved NIH3T3 cells stably expressing paxillin-GFP were stimulated with 2 μM
LPA and the movement of adhesions was analyzed using TIRF microscopy as described in Materials and Methods. Cells were filmed for 7 minutes before addition
of LPA and 7 minutes after addition of LPA (arrows indicate representative adhesions). Adhesions present at time 0 were pseudo-colored green (left panels) and
adhesions present at 7 minutes were colored red (middle panels). Movement of the individual adhesions was revealed using the merged images (right panels) and
analyzed as described in Materials and Methods. (B) Quantification of adhesion movement by LPA in NIH3T3 cells expressing paxillin-GFP was determined as
described in Materials and Methods. The experiment was performed three times, and five to seven cells were analyzed per experimental condition. (C) Western blot
analysis of FAK activation by LPA in Rat2 cells stably expressing GFP-FAK. Cells were stimulated with LPA for 5 minutes and GFP-FAK phosphorylation was
assessed using antibody against phosphorylated tyrosine (pTyr) as described in Materials and Methods. The increase in activation of MAP kinase was determined
by immunoblotting using antibodies against phosphorylated and total ERK (pERK and ERK, respectively). (D) LPA activation of endogenous FAK in Rat2 cells.
Cells were stimulated with LPA for 5 minutes and western blots were probed with antibody against phosphorylated Tyr397 (pY397) or anti-FAK antibody as
described in Materials and Methods.

movement of the adhesions over a 7-minute time period (Fig. 2A,B
and supplementary material Movie 3). As previously reported the
addition of LPA to serum starved cells induced a rapid increase in
the tyrosine phosphorylation of FAK (Fig. 2C,D). These data
indicate that LPA signaling is sufficient to induce changes in the
movement of mature adhesions found in the trailing edge and that
the activation of FAK is concomitant with this process.
Lack of FAK expression in fibroblasts results in an elongated
phenotype in the presence of serum, and failure to induce
adhesion movement and trailing-edge retraction

The knockdown of FAK using either small interference RNA
(siRNA) designed to specifically target rat FAK (Tilghman et al.,
2005) or small hairpin RNA (shRNA) to specifically target mouse
FAK resulted in an elongated cell morphology (Fig. 3A,B) when
cells were grown in the presence of serum. To confirm that the
observed elongation of the cells was due to the loss of FAK
expression, a Rat2 cell line was created that constitutively expressed
(at ~20% the level of endogenous FAK) chicken FAK tagged to
GFP (GFP-FAK), which was not knocked down by siRNA targeting
endogenous FAK (Fig. 3C). The morphology of cells expressing

GFP-FAK was indistinguishable from control cells expressing a
LacZeo transgene (Fig. 3D). Whereas FAK siRNA treatment
(targeting rat FAK) increased cell elongation in control Rat2 cells,
the GFP-FAK-expressing cells retained their more rounded
morphology (Fig. 3D). FAK immunostaining revealed that, in
control cells, FAK silencing resulted in the absence of endogenous
FAK in adhesions (Fig. 3D). By contrast, FAK siRNA treatment of
Rat2 cells expressing GFP-FAK did not decrease the expression of
GFP-FAK or alter its localization to adhesions (Fig. 3D). Therefore,
the changes in cellular morphology were a consequence of reduced
FAK expression and correlated with the loss of FAK from cell matrix
adhesions.
To examine whether FAK functions downstream of LPA to
stimulate adhesion dynamics and trailing-edge retraction, Rat2 cells
that stably expressed paxillin-GFP were treated with control or FAK
siRNA. Cells were serum starved for twelve hours and stimulated
with 2 μM LPA, and adhesion dynamics were measured using TIRF
microscopy (Fig. 4A). LPA readily induced dynamic movement of
adhesions in control cells but failed to do so in FAK-siRNA-treated
cells (Fig. 4B). This result is consistent with the failure of FAKsiRNA-treated cells to retract trailing edge in response to LPA.
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Consistent with these observations, addition of serum or LPA to
serum-starved control cells induced restoration of cell shape whereas
serum-starved FAK-knockdown cells largely maintained their
elongated morphology in response to either serum or LPA (Fig. 5).
These observations are consistent with LPA controlling trailing-edge
retraction and changes in cell shape through a receptor pathway
that requires FAK activation and downstream signaling.
Overexpression of specific RhoA-pathway components
rescues the FAK-knockdown phenotype

Journal of Cell Science

To determine the downstream effectors for FAK that contribute to
adhesion movement and trailing-edge retractions, we assessed the
role of RhoGEFs and putative Rho effectors. The RhoGEF, PDZRhoGEF has been shown to be an important effector of the LPA
receptor signaling pathway (Yamada et al., 2005). To investigate

the role of this GEF, Rat2 cells treated with FAK siRNA to block
endogenous FAK expression were transfected with Myc-tagged
PDZ-RhoGEF (Myc-PDZ-RhoGEF), Myc-tagged PDZ-RhoGEF
lacking Rho Dbl homology (DH) and pleckstrin homology (PH)
domains [Myc-PDZ-RhoGEF(1-585)] and Myc-tagged full-length
p115RhoGEF (Myc-p115RhoGEF). The expression level of each
of these three Rho GEFs was similar (Fig. 6A) and the localization
of GEFs was consistent with previously published data (Banerjee
and Wedegaertner, 2004). Both PDZ-RhoGEF and PDZRhoGEF(1-585) but not p115RhoGEF localized to the actin
cytoskeleton (data not shown). As shown in Fig. 6B, the expression
of wild-type PDZ-RhoGEF but not PDZ-RhoGEF(1-585) or fulllength p115RhoGEF restored changes in cell shape induced by
treatment of Rat2 cells with FAK siRNA. These data indicate that
Rho activation by PDZ-RhoGEF is required downstream of FAK

Fig. 3. Knockdown of FAK expression induces cell elongation. (A,B) Phase-contrast images, western blot analysis of FAK protein expression and quantification of
cell elongation in control cells, FAK-siRNA treated Rat2 cells (A) or FAK-shRNA treated NIH3T3 cells (B) . The extent of FAK knockdown was determined by
western blotting and compared with expression of paxillin. (C) Western blot analysis of FAK expression in wild-type Rat2 cells, Rat2 cells expressing LacZeo and
Rat2 cells expressing GFP-tagged chicken FAK. Endogenous FAK expression was substantially reduced in wild-type (wt), control-transfected cells (Lzeo) and in
cells expressing GFP-tagged chicken FAK (GFP-FAK) following treatment with FAK siRNA (right three lanes) as compared with control siRNA-treated cells (left
three lanes).The level of expression of GFP-tagged chicken FAK remained unchanged upon treatment with either control or FAK siRNA. Actin levels indicate the
equal loading of sample in each lane. (D) Expression of GFP-FAK decreases cell elongation following FAK knockdown using siRNA. The images on the left
illustrate the reduced immunostaining of FAK observed in cells treated with FAK siRNA. The images on the right illustrate the continued expression of GFPtagged chicken FAK (GFP-FAK) in cells treated with control and FAK siRNA. Graphs panels A, B and D show cell-shape measurements that were assessed by
determining the elongation factor for cells treated with either siRNAs or shRNAs.
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Fig. 4. LPA-induced adhesion
movement is FAK dependent.
(A) Analysis of adhesion
movement in response to 2 μM
LPA. Control or FAK-siRNAtreated Rat2 cells stably
expressing paxillin-GFP were
plated on fibronectin-coated
glass T dishes i medium
containing 10% serum. The
following day, cells were
serum-starved for 12 hours and
stimulated with 2 μM LPA.
Adhesion movement was
analyzed using TIRF
microscopy as described in Fig.
3. Cells were filmed for 27
minutes before the addition of
LPA and 27 minutes after the
addition of LPA.
(B) Quantification of dynamic
adhesions was assessed as
described in Materials and
Methods (arrows indicate
representative adhesions). The
experiment was performed
three times, six to eight cells
were analyzed per
experimental condition.

in regulating adhesion dynamics that are necessary for rear
retraction and restoration of cell shape. To assess which putative
Rho effectors might be important for the restoration of cell shape
in FAK-deficient NIH3T3 cells, we expressed two different active
Rho-effector-domain mutants (Palazzo et al., 2001; ToselloTrampont et al., 2003) in NIH3T3 cells whose FAK expression
was downregulated (Fig. 6C). As shown in Fig. 6D, expression of
a GFP-tagged RhoA effector mutant (RhoAG14VF39V) that can
activate both mammalian diaphanous (DIAPH1; hereafter referred

Fig. 5. FAK is required for LPAmediated induction of trailing-edge
retraction and the restoration of normal
morphology. (A) Representative images
of and α-tubulin staining of control and
FAK-siRNA-treated cells that were
either serum starved, or serum starved
and stimulated with 10% serum or 2
μM LPA. (B) The elongation factor for
siRNA-treated cells was determined
after treating cells that had been serum
starved overnight with serum or with
LPA for 7 hours. The experiment was
repeated twice and 50-60 cells were
analyzed per condition.

to as mDia) and ROCK efficiently rescued the elongated phenotype
induced by FAK deficiency. By contrast, the negative control GFPtagged PDZ-RhoGEF(561-585) [GFP-PDZ-RhoGEF(561-585)],
the actin-binding domain of PDZ-RhoGEF fused to GFP or a Rho
effector mutant that activates only mDia (RhoAG14VF39A), all
failed to rescue the elongated phenotype in FAK-deficient cells
(Fig. 6D). These data indicate that FAK and PDZ-RhoGEF
cooperate to activate the Rho/ROCK pathway and induce trailingedge retraction.

Journal of Cell Science
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Fig. 6. Ectopic expression of PDZ-RhoGEF and
RhoA-effector-domain mutant rescues
elongation induced by knockdown of FAK
expression. (A) NIH3T3 cells were transiently
transfected with Myc-PDZ-RhoGEF, Mycp115RhoGEF and Myc-PDZ-RhoGEF(1-585).
Twenty-four hours after transfection, lysates
were prepared and blotted with anti-Myc
antibody. (B) Quantification of cell elongation.
The shape of FAK-siRNA-treated cells that
express different RhoGEF constructs was
determined by measuring the elongation factor
for individual cells. (C) FAK-shRNA-treated
cells were transiently transfected with control
non-functional PDZ-RhoGEF(561-585)-GFP ,
G14VRhoA/F39A-GFP or G14VRhoA/F39VGFP. Twenty-four hours after transfection,
lysates were prepared and blotted using antiGFP antibody. The expression of GFP-tagged
proteins was determined by immunoblotting
individual lysates with anti-GFP and with antiERK antibodies to ensure equal loading of
lysate samples. (D) Quantification of cell
elongation in FAK-shRNA-treated cells
expressing different RhoA-effector-domain
mutants.

PDZ-RhoGEF–Rho/ROCK signaling is necessary for LPAinduced trailing-edge retraction and stimulation of adhesion
dynamics

We next sought to determine whether PDZ-RhoGEF forms a complex
with FAK and localizes to FAK-containing adhesions. Myc-PDZRhoGEF(1-585) or Myc-p115RhoGEF was overexpressed in
HEK293T cells, as was GFP-FAK. As shown in Fig. 7A, GFP-FAK
was readily detected in immune complexes with Myc-PDZRhoGEF(1-585) but not in immune complexes with Mycp115RhoGEF. To test whether FAK and PDZ-RhoGEF co-localized
in adhesions we overexpressed Myc-PDZ-RhoGEF, Myc-PDZRhoGEF(1-585) and Myc-p115RhoGEF in Rat2 cells stably
expressing GFP-FAK. We observed that Myc-PDZ-RhoGEF, MycPDZ-RhoGEF(1-585) but not Myc-p115RhoGEF localized to FAK
containing adhesions (Fig. 7B). To confirm the requirement for PDZRhoGEF in a signaling pathway that controls cell elongation
downstream of the LPA receptor, Rat2 cells were treated with PDZRhoGEF siRNA to attenuate PDZ-RhoGEF expression (Fig. 7C).
PDZ-RhoGEF siRNA-treated cells exhibited elongated phenotype
even in the presence of serum (Fig. 7C, phase images); a phenotype
comparable to that observed in FAK-siRNA-treated cells. Stimulation
of serum-starved control and PDZ-RhoGEF-siRNA-treated cells with
2 μM LPA revealed that the PDZ-RhoGEF-siRNA-treated cells
remained elongated (Fig. 7D). TIRF microscopy was used to measure
adhesion dynamics in LPA-stimulated and serum-starved control and
PDZ-RhoGEF-siRNA-treated Rat2 cells stably expressing paxillinGFP (Fig. 8A). As shown in Fig. 8B LPA stimulation of control cells
but not PDZ-RhoGEF-siRNA-treated cells induced adhesion

dynamics (Fig. 8B). These data provide additional support for the
role of PDZ-RhoGEF in a FAK-dependent pathway that contributes
to the regulation of rear retraction and adhesion movement.
Since, the Rho-effector-domain mutant that can not activate
ROCK failed to rescue the FAK knockdown phenotype, we reasoned
that shRNA-mediated knockdown of ROCKI and or ROCKII would
prevent LPA from stimulating adhesion movement and trailing-edge
retraction in response to LPA. As shown in Fig. 9A, shRNAmediated knockdown of ROCKII expression (but not ROCKI
expression) induced cell elongation in the presence of serum. The
phenotype of ROCKII-knockdown cells, however, was distinct from
that observed for FAK-knockdown cells (shown in Fig. 3A,B), in
that the cell bodies exhibit a somewhat flatter morphology. By
contrast, the knockdown of ROCKI substantially impaired formation
of mature adhesions and actin stress fibers (Fig. 9B and data not
shown), which is consistent with recent observations (Totsukawa
et al., 2004; Yoneda et al., 2005). We observed that LPA failed to
induce adhesion movement in cells lacking either ROCKI or
ROCKII (Fig. 9B,C), indicating that both ROCKI and ROCKII
contribute to the regulation of adhesion mobility. As shown in Fig.
9D, knockdown of ROCKII prevented the LPA-dependent
stimulation of trailing-edge retraction and the concomitant decrease
in cell elongation. These results support a model in which LPA
activation of Gα12 and Gα13 (members heterotrimeric G protein
family) leads to activation of FAK–PDZ-RhoGEF–Rho/ROCKII
pathway that regulates the dynamics of mature adhesions, which –
in turn – lead to trailing-edge retraction and concomitant decrease
in cell elongation in serum-starved cells treated with LPA.

FAK-dependent trailing-edge retraction
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Discussion
In this report we show that serum deprivation of rodent fibroblasts
markedly reduced trailing-edge retraction without having a
significant effect on lamellipodia protrusive activity at the leading
edge. The perturbation in trailing-edge retraction results in an
elongated cell morphology following overnight serum starvation.
Addition of LPA to serum-starved cells stimulates rear retraction
and decreases cell elongation, and provides a model that parallels
events within the trailing edge of a migrating fibroblast. Importantly,
trailing-edge retraction requires LPA-induced stimulation of the
dynamic movement of mature adhesions. Using this model, we have

Fig. 7. GFP-FAK coimmunoprecipitates and localizes
with co-expressed Myc-PDZRhoGEF and Myc-PDZRhoGEF(1-585). (A) HEK293T
cells were transfected with with
0.5 μg GFP-FAK and Myc-PDZRhoGEF(1-585) or Mycp115RhoGEF. To measure the
amount of FAK in complex with
the individual GEF proteins,
immune complexes were isolated
from lysates using anti-Myc
antibody, and subjected to SDSPAGE and western blotting with
anti-FAK (top panel) or anti-GFP
(second panel) antibodies. The
expression of GEF proteins and
GFP-FAK in lysates was
determined by SDS-PAGE and
immunoblotting lysates directly
with anti-Myc or anti-GFP
antibodies (bottom two panels).
(B) Rat2 cells stably expressing
GFP-FAK were transiently
transfected with Myc-PDZRhoGEF, Myc-PDZ-RhoGEF(1585) or Myc-p115RhoGEF,
detached and seeded on
fibronectin coated glass T dishes,
fixed and Myc stained visualized
using TIRF microscopy. Images
show the colocalization of GFPFAK and Myc-tagged PDZRhoGEF (top and middle
panels), and the lack of
colocalization of GFP-FAK and
Myc-tagged p115RhoGEF.
(C) Western blot analysis of
endogenous PDZ-RhoGEF
expression and phase-contrast
images of control Rat2 cells and
Rat2 cells treated with PDZRhoGEF siRNA. (D) Fluorescent
images and cell elongation
quantification of control Rat2
cells and Rat2 cells treated with
PDZ-RhoGEF siRNA .
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identified specific signaling components that contribute to trailingedge retraction in fibroblasts in response to LPA. LPA-induced
retraction of the trailing edge requires FAK. The siRNA-mediated
attenuation of FAK expression blocks LPA induction of adhesion
dynamics, trailing-edge retraction and restoration of cell shape,
suggesting that dynamic remodeling of adhesions is necessary for
trailing-edge retraction. LPA induced changes in adhesion dynamics;
trailing-edge retraction and cell elongation also required PDZRhoGEF. The siRNA-mediated knockdown of PDZ-RhoGEF
blocked LPA-induced adhesion dynamics and prevented the
restoration of cell shape. Furthermore, expression of PDZ-RhoGEF

Journal of Cell Science
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Fig. 8. PDZ-RhoGEF is required
for LPA induction of adhesion
movement. (A) Analysis of
adhesion movement in response to
LPA. Control Rat2 cells and Rat2
cells treated with PDZ-RhoGEF
siRNA that stably expressed
paxillin-GFP were plated on
fibronectin-coated dishes in the
presence of medium containing
10% serum. The following day,
cells were serum starved for 12-16
hours and then stimulated with
2 μM LPA. Adhesion dynamic
was analyzed using TIRF
microscopy as described in
Materials and Methods. Cells
were filmed for 21 minutes before
the addition of 2 μM LPA and 27
minutes after the addition of 2 μM
LPA. (B) Quantification of
dynamic adhesions (arrows
indicate representative adhesions).
The experiment was performed
twice with five to seven cells
analyzed per condition.

rescues the FAK-siRNA-induced phenotype with respect to cell
elongation, i.e. cells are less elongated. In addition, PDZ-RhoGEF
co-immunoprecipitated with FAK and colocalizes with FAKcontaining adhesions, which suggests that activation of FAK and
PDZ-RhoGEF are closely coupled. Finally, two lines of evidence
suggest that ROCKII is one of the major targets of activated Rho
in response to LPA. Expression of a Rho effector mutant that
preferentially activates mDia failed to rescue the elongated
phenotype of FAK knockdown cells; whereas a mutant that activates
both mDia and ROCK pathways rescued the elongated phenotype
of FAK-siRNA-treated cells. In addition, knockdown of ROCKII
but not ROCKI induced a phenotype that parallels that observed in
FAK-deficient cells with respect to cell elongation, and retention
of stress fibers and adhesions structures. Our observations are
consistent with a model in which LPA binding to its receptor
stimulates activation of Gα12 and Gα13, FAK, and the closely
coupled activation of PDZ-RhoGEF, Rho and ROCKII, leading to
spatial (trailing edge) stimulation of adhesion dynamics through a
localized increase in contractility, retraction of the cell rear and
decrease in cell elongation.
There is abundant evidence that G-protein-coupled receptors
(GPCRs), such as those for LPA, activate Rho and Rho-dependent
signaling pathways through the Gα12 and Gα13 family of
heterotrimeric G proteins (Barr et al., 1997; Gohla et al., 1998;

Majumdar et al., 1999; Offermanns et al., 1994). The RhoGEFs,
p115RhoGEF, PDZRhoGEF and leukemia-associated RhoGEF
(LARG ) contain a regulator of G-protein-signaling (RGS) domain
that binds activated Gα12/13 resulting in RhoGEF activation
(Wang et al., 2004). Thus, the RGS-RhoGEFs are thought to serve
as effectors of activated Gα12/13 and as molecular bridges between
heterotrimeric G proteins and the Rho network (Fukuhara et al.,
1999; Reuther et al., 2001; Togashi et al., 2000; Zheng et al., 1995).
A number of studies show that activation of tyrosine kinases
by GPCRs is required for the efficient stimulation of Rho and
Rho signaling (for a review, see Sah et al., 2000). Indeed, many
GPCRs are potent activators of FAK, suggesting a close link
between FAK activation and Rho signaling (Hordijk et al., 1994;
Luttrell et al., 1997; Seufferlein and Rozengurt, 1994).
Furthermore, it has been reported that stimulation of Gα12
and Gα13 induces FAK-dependent PDZ-RhoGEF tyrosine
phosphorylation leading to enhanced activation of Rho (Chikumi
et al., 2002). How FAK is participating in Gα12 and Gα13
signaling to Rho remains unclear. The observation that FAK forms
a complex with PDZ-RhoGEF and the report that PDZ-RhoGEF
forms oligomers (Chikumi et al., 2004), lead us to speculate that
LPA-mediated activation of Gα12 and Gα13 may induce
oligomerization of PDZ-RhoGEF and concomitant dimerization
of FAK, then leading to transphosphorylation and activation of
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Fig. 9. LPA induced adhesion
movement requires ROCKI and
ROCKII. (A) Western blot
analysis of ROCKI and ROCKII
protein expression in control
NIH3T3 cells and NIH3T3 cells
treated with shRNA targeting
FAK, ROCKI or ROCKII (top
panel). Micrographs show
phase-contrast images of control
NIH3T3 cells and NIH3T3 cells
treated with shRNA targeting
ROCKI or ROCKII. (B) Control
NIH3T3 cells and NIH3T3 cells
treated with shRNA targeting
ROCKI or ROCKII were serum
starved for 12 hours. Following
starvation, cells were stimulated
with 2 μM LPA and adhesion
movement was visualized by
TIRF microscopy.
(C) Quantification of adhesion
movement (as described in
Materials and Methods) in
unstimulated serum-starved cells
and in serum-starved cells
stimulated with LPA (arrows
indicate representative mobile
adhesions). The experiment was
performed twice with six to eight
cells analyzed per experimental
condition. (D) Quantification of
cellular elongation in LPAstimulated control cells and
ROCKII-shRNA-treated cells.
The experiment was performed
twice.

FAK within such complexes. Alternatively, LPA stimulation of
acidic phospholipids (such as PtdIns(4,5)P2) might activate FAK
directly, as recently demonstrated (Cai et al., 2008). We speculate
that activated FAK phosphorylates PDZ-RhoGEF, thereby
stimulating GEF activity and GTP binding to Rho, and that this
localized activation of Rho leads to activation of effectors at or
proximal to adhesion sites.
It has been shown previously that LPA stimulation of serumstarved neuronal cells that had been treated with ROCK inhibitor
resulted in the failure of LPA to induce cell shape changes, rapid
neurite retraction and cell rounding (Jalink et al., 1993; Kranenburg
et al., 1999). However, our study did not delineate the contribution
of ROCKI and ROCKII in the process of LPA-induced neurite
retraction. More relevant to our study are the observations that
knockdown of ROCKII but not ROCKI yields a cellular phenotype
similar to that observed in response to FAK knockdown with respect
to cell shape, stress fiber augmentation and loss of dynamic
adhesions (Yoneda et al., 2005). In addition, recent studies have
shown that Rho-dependent breakdown of cell-cell adhesions
requires ROCKII but not ROCKI (Samarin et al., 2007). Therefore,

the studies by Jalink et al. and Kranenburg et al. indicate that
ROCKII plays a role in the induction of adhesion-complex dynamics
and adhesion-complex breakdown. Recent evidence indicates that
ROCKI rather than ROCKII is important for stress fiber formation
(Yoneda et al., 2005). ROCKII appears to function in the regulation
of microfilament bundling at the focal adhesion site and is involved
in phagocytosis of matrix-coated beads, a function not sensitive to
ROCKI depletion.
The effects of ROCKII on adhesion movement in the trailing
edge of fibroblasts could be attributed to the induction of localized
activation of myosin. We speculate that ROCKII-dependent tension
at the trailing-edge adhesions during LPA stimulation contributes
to the force that promotes inward movement of focal adhesions and,
ultimately, their disassembly. In cells with attenuated expression of
FAK, PDZ-RhoGEF or ROCKII adhesions remained stable even
after stimulation with LPA, indicating that this pathway is important
in regulating localized changes in contractility. This observation
suggests that adhesion turnover requires localized modulation of
myosin activity that is provided by the localized activation of the
FAK-GEF-Rho/ROCKII pathway.
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Materials and Methods

Immunoprecipitation experiments

Cell culture, plasmids and siRNAs

Twenty-four hours after transient transfection with indicated expression vectors
cells were washed with ice-cold PBS, and lysed in immuno-precipitation (IP) buffer
(50 mM Tris-HCl pH 7.6, 160 mM NaCl, 0.5 mM EDTA/EGTA, 1% Triton X100, 10% glycerol, 1 mM PMSF and 1 μg/ml leupeptin). Cell extracts were clarified
by centrifugation at 13,000 g and cell supernatants were applied to agarose
beads (10% of total volume) conjugated to anti-Myc (4A6) antibody
(UpstateBiochemicals Inc.). Immunoprecipitation was carried out for 2 hours at
4°C; immune complexes were washed three times with IP buffer and boiled in
1⫻ sample buffer. Samples were processed for SDS-PAGE and western blotting
as described above.

Rat2 and HEK293T cells were maintained in Dulbecco’s modiefied Eagle’s medium
(DMEM) plus 10% fetal calf serum (FCS; GibcoBRL) at 37°C in 5% CO2. NIH3T3
cells were maintained in DMEM plus 10% calf serum (GibcoBRL), at 37°C in
5% CO2. For FAK- and PDZ-RhoGEF-knockdown experiments, cells were
transfected with siRNA oligonucleotides specifically targeting rat FAK, PDZRhoGEF (available as GTRAP48; Dharmacon pool) or with control siRNA
oligonucleotides using Ca2+ phosphate as previously described (Tilghman et al.,
2005). FAK, ROCKI and ROCKII shRNA expressing plasmids were obtained
from Sigma. For transient expression of Myc-PDZ-RhoGEF, Myc-PDZRhoGEF(1-585), Myc-p115RhoGEF and GFP-FAK, Rat2 or HEK293T cells
were plated in the presence of 10% serum in 100 mm2 plastic culture dishes at
densities of 4⫻105 and 1.5⫻106 cells per dish, respectively. The next day cells
were transfected using Polyfect reagent (Qiagen) with 0.25 μg or 0.5 μg of
the designated plasmid. Twenty-four hours later cells were processed for
experiments.
The Flp-In System (Invitrogen) was used to create stable cell lines expressing GFPtagged or red fluorescent protein (mRFP)-tagged proteins. Briefly, NIH3T3-LacZeo
or RAT2-LacZeo cell lines with a flp recombinase target (FRT) site integrated in the
genome were created. cDNAs encoding either paxillin-GFP, GFP-FAK or βactinmRFP fusion proteins were cloned into the NheI-BamHI or HindIII-NotI sites of the
pcDNA5/FRT vector. The host cells were then co-transfected with pOG44 plasmid
encoding Flp recombinase and either pcDNA5/FRT-paxillin-GFP, pcDNA5/FRT-GFPFAK or pcDNA5/FRT βactin-mRFP and recombinant cell lines were selected
according to the manufacturer’s instructions. Stable clones were analyzed for
expression of paxillin-GFP, GFP-FAK and βactin–mRFP by fluorescent microscopy
and western blotting.
Myc-PDZ-RhoGEF, Myc-p115RhoGEF and GFP-PDZ-RhoGEF(561-585)
plasmids were engineered as described elsewhere (Banerjee and Wedegaertner,
2004). Paxillin-GFP was a generous gift from Rick Horwitz (University of Virginia,
Charlottsville, VA) GFP-FAK was generated by cloning FAK from pCMV-Myc
–FAK vector (Xiong and Parsons, 1997) into vector pEGFP-C1 (Clontech, CA).
βactin–mRFP was a generous gift from the laboratory of Frank Getler (MIT,
Cambridge, MA). RhoA-effector-domain mutants were a generous gift from
Kodi Ravichandran (University of Virginia). FAK, ROCKI and ROCKII
shRNA plasmids were obtained from the Sigma shRNA library. Lentiviral
packaging plasmids pMDG and pCMVδR 8.2 were generous gift from
David Rekosh (University of Virginia). Lentiviral production was performed
according to Sigma protocol. The organization of adhesions in cells whose
expression of FAK, PDZ-RhoGEF, ROCKI and ROCKII was knocked down were
assessed by immunostaining for FAK and paxillin (supplementary material Fig.
S1).

Serum starvation and LPA-stimulation experiments
Serum deprivation is defined as removal of serum up to 6 hours. Serum starvation
is defined as removal of serum for 12-16 hours. Transfected and untransfected cells
were plated overnight on glass T dishes or plastic dishes coated with fibronectin (1
μg/ml) in the presence of medium containing 10% serum. The following day, culture
medium was changed to medium containing (10%) serum or not, or to serum-free
medium plus LPA (2 μM).

Western blotting

Cells were lysed in 200 μl of RIPA buffer (50 mM HEPES pH 7.4, 1% Triton X100, 1% sodium deoxycholate, 0.1% SDS, 0.1 M NaCl, 1 mM sodium
orthovanadate, 0.1 M sodium pyrophosphate, 100 mM NaF and 1 mM PMSF).
Lysates were clarified by centrifugation at 13,000 g for 10 minutes. Clarified lysates
were boiled in 1⫻ sample buffer (0.04 M Tris-HCl pH 6.8, 1% SDS, 1% βmercaptoethanol and 10% glycerol) for 10 minutes and resolved by SDS-PAGE.
Proteins were transferred to Immobilon membrane (Whatman) and blocked with
5% BSA in PBS (140 mM NaCl, 0.27 mM KCl, 0.43 mM Na2HPO4 . 7H2O, 0.14
mM KH2PO4 pH 7.3), 0.1% Tween 20, pH 7.2 for 1 hour at room temperature.
Membranes were incubated overnight at 4°C with one of the following antibodies:
anti-actin (Zymed, 1:5000), anti-FAK polyclonal antibody (UpstateBiochemicals,
1:1000), anti-pY397 FAK polyclonal antibody (Biosource, 1:1000), anti-MAPK
monoclonal antibody (1:2000, Sigma), anti-phosphorylated-MAPK polyclonal
antibody (1:2000, gift from Michael J. Webber, University of Virginia), anti-GTRAP
48 (against PDZRhoGEF) monoclonal antibody (1:1000, BD Transduction), antiGFP polyclonal antibody (1:1000, Cell Signaling), anti tubulin monoclonal antibody
(1:5000, Sigma), anti-phosphorylated-tyrosine monoclonal antibody (4G10; 1:1000,
UpstateBiochemicals) or anti-Myc monoclonal antibody 9E10 (SantaCruz, 1:1000),
polyclonal anti-ROCKII antibody (1:1000, Upstate), monoclonal anti ROCKI/II
(1:1000, Upstate) and monoclonal anti-Paxillin antibody (1:1000, BD Transduction).
Membranes were subsequently probed with secondary antibodies linked to
horserasish peroxidase (HRP; Amersham). Western blot membranes were developed
using enhanced chemiluminescent substrate for detection of HRP (Amersham).
Western blot results were prepared using AlphaEaseFC (FluorChem 8800) for
Windows software.

Analysis of adhesion movement
Adhesion movements were visualized using TIRF microscopy in serum-deprived
NIH3T3 or Rat2 cells that stably expressed paxillin-GFP, before and after the addition
of 2 μM LPA. Cells were maintained at 37° with a Bioptechs Delta T heated chamber
system. Cells were imaged using a Nikon Eclipse TE2000-E inverted microscope
equipped with a TIRF illuminator, a 488 argon laser and a 60⫻ DIC TIRF objective
(NA1.45) equipped with a Bioptechs objective heater. Images were acquired with a
Retiga 1300i CCD camera and the QCapture Pro software (Q Imaging). Adhesion
movement was quantified as described before (Smilenov et al., 1999) briefly; the
first frame of a movie was pseudo-colored green, the last frame pseudo-colored red
and the two images were merged. Adhesions that contained both red and green, and
thus appeared yellow, were scored as poorly dynamic. The fraction of adhesions that
move was scored to determine the percentage of red adhesions relative to total
adhesions in the first frame.

Phase microscopy

NIH3T3 cells stably expressing βactin-mRFP or Rat2 cells were serum-deprived in
the absence or presence of 2 μM LPA and filmed using a Zeiss Axiovert 135 TV
microscope equipped with a CCD camera MTI 176.

Immunostaining
Control cells, or FAK- or PDZ-RhoGEF-siRNA-treated Rat2 fibroblasts were plated
overnight on fibronectin-coated coverslips (1 μg/ml, Sigma) in medium containing
10% serum. Cells were either left untreated or serum-starved overnight and then
stimulated with 2 μM LPA with 0.1% carrier BSA or 10% fetal bovine serum (FBS)
for indicated times. Cells were fixed with 4% paraformaldehyde in PBS,
permeabilized with 0.5% Triton X-100 in PBS and blocked with 20% goat serum
in PBS. Cells were washed three times with PBS and immunostained with the
following antibodies: anti-tubulin B2-11 (Sigma, 1:5000) and anti-Myc 9E10
(1:250, SantaCruz). To visualize actin cells were treated with Alexa-Fluor-488conjugated phalloidin (Invitrogen, Inc.). To visualize microtubules or Myc-tagged
GEF constructs, cells were treated with secondary goat anti-mouse antibodies
conjugated to Alexa-Fluor-594 (1:2000, Invitrogen, Inc.). Fluorescent images were
acquired using a Nikon Eclipse E600 upright fluorescence microscope equipped
with a Hamamatsu ORCA CCD camera. Images were captured and analyzed with
OpenLab (Improvision) software.

Analysis of trailing-edge length and cell elongation
To measure the length of the trailing edge, a line was drawn from the tip of the trailing
edge towards the base of the nucleus. To measure the cell length, a line was drawn
from the center of the nucleus to the furthest visible microtubule tip. To measure the
cell width, a second line was drawn across the cell passing through the center of the
nucleus at a 90° angle to the first line. To calculate the ‘elongation factor’, the cell
length was divided by cell width.

Analysis of lamellipodia protrusion

NIH3T3 cells stably expressing βactin-mRFP or Rat2 cells were plated in medium
containing 10% serum on fibronectin-coated (1 μg/ml) glass T dishes at the density
of 3⫻104 cells per dish. The next day, serum-containing medium was changed to
serum-free medium or to serum-free medium containing 2 μM LPA. After 6 hours
cells were filmed for a total of 15-20 minutes, collecting one image every 20 seconds
using TIRF (for NIH3T3 cells) or DIC (for Rat2 cells) microscopy. Protrusion rates
were calculated using Image J software (Wayne Rasband, National Institute of Health,
MA).

Statistics
Statistical analysis was done using non-parametric, non-assuming Gaussian
distribution Mann-Whitney t-test using Prism software. ***P=0.001, **P=0.01 and
*P=0.05 denote statistical differences.
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